Emergent BioSolutions is selling a manufacturing site in Baltimore — which has a history of contaminated Covid-19 vaccines — for $36.5 million to India-headquartered CDMO Syngene.
This purchase marks Syngene’s first manufacturing site in the US. It ...
↧
